Copyright
©2014 Baishideng Publishing Group Inc.
World J Immunol. Nov 27, 2014; 4(3): 130-140
Published online Nov 27, 2014. doi: 10.5411/wji.v4.i3.130
Published online Nov 27, 2014. doi: 10.5411/wji.v4.i3.130
Ref. | Year | Allergen | Study design | No. of patients | Findings |
Quirino et al[84] | 1996 | Grass pollen | Double-blind, double-dummy | SCIT (n = 10) SLIT (n = 10) No placebo group | Significant reduction in symptoms and medications for SCIT and SLIT groups ↑ Total specific IgG, ↑specific IgG4 and ↓skin reactivity for SCIT only |
Mungan et al[83] | 1999 | Dust mite | Single-blind, placebo controlled | SCIT (n = 10) SLIT (n = 15) Placebo (n = 11) | ↓ Rhinitis symptoms with SLIT ↓ Skin reactivity with SCIT ↑ Specific IgG4 with SCIT |
Khinchi et al[82] | 2004 | Birch pollen | Randomized, double-blind, double-dummy, placebo-controlled | SCIT (n = 21) SLIT (n = 18) Placebo (n = 19) | Significant reduction in symptoms and medications for SCIT vs placebo and SLIT vs placebo No difference between SCIT and SLIT groups |
Mauro et al[86] | 2007 | Birch pollen | Randomized, double-blind, double-dummy | SCIT (n = 19) SLIT (n = 15) | No difference in mean symptom and medication score between SCIT and SLIT Specific IgG4 with SCIT |
Tahamiler et al[88] | 2008 | Dust mite | Open label, randomized | SCIT (n = 96) SLIT (n = 97) | ↓ Rhinitis and conjunctivitis symptoms scores and nasal provocation score with SCIT and SLIT (greater improvement with SCIT) |
Eifan et al[85] | 2010 | Dust mite | Open label, randomized, controlled | SCIT (n = 16) SLIT (n = 16) Pharmacotherapy (n = 16) | ↓ Rhinitis and asthma symptom score, total medication score ↓ Skin reactivitiy with SCIT and SLIT ↓ Specific IgE with SCIT and SLIT |
Keles et al[87] | 2011 | Dust mite | Open label, randomized, controlled | SCIT (n = 11) SLIT (n = 13) SCIT plus SLIT (n = 14) Pharmacotherapy (n = 12) | Reduction in total symptom score and total medication score in all immunotherapy groups ↓ Skin reactivity with SCIT ↑ Specific IgG4 for SCIT and SCIT plus SLIT |
Yukselen et al[89] | 2012 | Dust mite | Randomized, double-blind, double-dummy, placebo-controlled | SCIT (n = 10) SLIT (n = 11) Placebo (n = 10 ) | Significant reduction in rhinitis and astma symptom score with SCIT Skin reactivity with SCIT and SLIT ↑ Specific IgG4 with SCIT |
- Citation: Yukselen A, Kendirli SG. Subcutaneous and sublingual immunotherapy: Where do we stand? World J Immunol 2014; 4(3): 130-140
- URL: https://www.wjgnet.com/2219-2824/full/v4/i3/130.htm
- DOI: https://dx.doi.org/10.5411/wji.v4.i3.130